Nabsys, Indiana University School of Medicine Launch Multiyear Collaboration to Map Blood Cancer Genomes

Nabsys is launching a multiyear research collaboration with Indiana University School of Medicine to develop electronic genome mapping (EGM) technology for blood cancers. The initial goal of the collaboration is to use the OhmX™ platform to detect structural variants in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Nabsys plans to present related research findings at the Cancer Genomics Consortium (CGC) annual meeting in August, including one oral presentation and three posters.